HCWB HCW Biologics Inc.

Nasdaq hcwbiologics.com


$ 4.45 $ 0.28 (6.64 %)    

Tuesday, 14-Oct-2025 16:45:32 EDT
QQQ $ 598.52 $ -4.01 (-0.67 %)
DIA $ 462.82 $ 2.03 (0.44 %)
SPY $ 662.64 $ -0.81 (-0.12 %)
TLT $ 90.63 $ 0.29 (0.32 %)
GLD $ 382.68 $ 2.70 (0.71 %)
$ 4.5
$ 4.14
$ 4.45 x 2
$ 4.55 x 50
$ 4.11 - $ 4.55
$ 2.77 - $ 100.80
49,593
na
9.68M
$ 0.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-18-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-hcw-biologics-stock-surging-102-overnight

HCW Biologics' stock jumped 102.72% to $6.73 after the company revealed the successful development of second-generation T-c...

 hcw-biologics-inc-awarded-patent-number-us-12398189-b2-for-methods-of-activating-regulatory-t-cells

eyJzdWIiOiJiNWI5OThjOS03NjVhLTQ2YjAtYTQ3Yy0zMjBiNzEyNjg4N2UiLCJ2ZXIiOiIxOGVhMGE1Mi0yNWE5LTQzZDktYWY3ZS1iMDIyNjg2OGIzYmIiLCJleHA...

 hcw-biologics-shares-soar-on-breakthrough-second-generation-cancer-immunotherapy

HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generat...

 hcw-biologics-shares-surge-after-unveiling-next-gen-cancer-immunotherapy-platform

HCW Biologics shares jump after unveiling TRBC-based fusion therapy that enhances immune response and shows strong preclinical ...

 hcw-biologics-announces-breakthrough-in-second-generation-pembrolizumab-based-immunotherapy-for-solid-tumors-showing-enhanced-immune-activation-and-tumor-infiltration

Company's pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by...

 hcw-biologics-q2-eps-679-misses-180-estimate-sales-6550k-miss-7000m-estimate

HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(6.79) per share which missed the analyst consensus estimate of $1.80...

 hcw-biologics-says-payment-date-extended-for-license-fee-wy-biotech-to-confirm-wiring-of-7m-on-or-before-sept-30

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION